Opendata, web and dolomites

Neuroheart TERMINATED

Cardiovascular Molecular Imaging for Personalized Tailored Treatment

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Neuroheart project word cloud

Explore the words cloud of the Neuroheart project. It provides you a very rough idea of what is the project "Neuroheart" about.

subsequent    mciropet    wistar    geometric    appropriate    thereby    hopkins    drug    life    regional    coronary    guided    patients    johns    contributes    rat    rats    economy    positron    prior    personalized    deterioration    insult    molecular    perspective    ligation    billion    myocardial    therapeutic    frequent    imaging    relationship    alterations    multiple    objectives    clinic    pet    cardiac    ischemic    expensive    small    animal    tomography    pathophysiology    relevance    technique    infarction    doses    model    scan    determined    university    angiotensin    radiolabelled    emission    heart    transfer    antiras    ligand    cutting    receptor    agents    mi    severe    abnormalities    pharmaceutical    economic    remodelling    artery    tracers    neurohumoral    subsequently    patient    blocker    hearts    magnetic    left    resonance    edge    burden    initiation    degrees    individualized    sufficient    optimize    global    ventricular    micropet    employed    fatal    quality    at1    cardioneuronal    performed    treatment    196    reduce    envisage    optimization    diseases    single    dose    estimate    hf    highest    vivo   

Project "Neuroheart" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT 

Organization address
address: JOSEF-SCHNEIDER-STRASSE 2
city: WURZBURG
postcode: 97080
website: www.uk-wuerzburg.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 239˙860 €
 EC max contribution 239˙860 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2015
 Funding Scheme MSCA-IF-GF
 Starting year 2017
 Duration (year-month-day) from 2017-01-01   to  2019-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT DE (WURZBURG) coordinator 239˙860.00
2    JOHNS HOPKINS UNIVERSITY US (BALTIMORE) partner 0.00

Map

 Project objective

Objectives of the proposal: Heart Failure (HF) is estimated to cost the EU economy €196 billion a year. Currently, patients are treated with the highest pharmaceutical doses of antiRAS agents, which cause severe side effects and reduce the patients’ quality of life. Moreover, treatment responses are highly variable. This study aims to enable imaging-guided treatment optimization by using a radiolabelled novel angiotensin 1 receptor (AT1) blocker analogue in a small animal model of myocardial infarction (MI). Positron emission tomography (PET) as a cutting-edge method of evaluating HF pathophysiology at a molecular level will be employed to optimize treatment. How the objectives will be achieved: MI will be obtained by ligation of the coronary artery in Wistar rats. Subsequently, PET imaging with a dedicated small animal system (mciroPET) will be performed. A multiple set of cardioneuronal PET tracers provided by the partner institution at Johns Hopkins University will be used to measure the extent of global and regional neurohumoral abnormalities in rat hearts following different degrees of ischemic insult. The relationship between neurohumoral system alterations and subsequent left ventricular remodelling will be determined by microPET and Magnetic Resonance Imaging to assess deterioration of ventricular geometric parameters. Using the novel AT1-ligand, imaging-guided dose-derived therapeutic concepts for Wistar rats will be established in vivo with the aim to transfer this technique to the clinic in a long term perspective. Relevance to the Work Programme: I envisage that in the future a single cardiac PET scan prior to treatment initiation will be sufficient to estimate the appropriate drug dose in any given HF patient. This new concept of individualized drug dose determination has the potential to lead to personalized treatment for one of the most frequent fatal and expensive diseases and thereby contributes to the reduction of the economic burden of the EU.

 Publications

year authors and title journal last update
List of publications.
2019 Rudolf A. Werner, Xinyu Chen, Steven P. Rowe, Constantin Lapa, Mehrbod S. Javadi, Takahiro Higuchi
Recent paradigm shifts in molecular cardiac imaging—Establishing precision cardiology through novel 18F-labeled PET radiotracers
published pages: , ISSN: 1050-1738, DOI: 10.1016/j.tcm.2019.02.007
Trends in Cardiovascular Medicine 2019-04-18
2018 Rudolf A. Werner, Ryohei Kobayashi, Mehrbod Som Javadi, Zoe Köck, Hiroshi Wakabayashi, Stefan Unterecker, Kenichi Nakajima, Constantin Lapa, Andreas Menke, Takahiro Higuchi
Impact of Novel Antidepressants on Cardiac 123 I-Metaiodobenzylguanidine Uptake: Experimental Studies on SK-N-SH Cells and Healthy Rabbits
published pages: 1099-1103, ISSN: 0161-5505, DOI: 10.2967/jnumed.117.206045
Journal of Nuclear Medicine 59/7 2019-03-12
2018 Rudolf A. Werner, Xinyu Chen, Mitsuru Hirano, Steven P. Rowe, Constantin Lapa, Mehrbod S. Javadi, Takahiro Higuchi
SPECT vs. PET in cardiac innervation imaging: clash of the titans
published pages: 293-303, ISSN: 2281-5872, DOI: 10.1007/s40336-018-0289-4
Clinical and Translational Imaging 6/4 2019-03-12
2018 Rudolf A. Werner, Xinyu Chen, Yoshifumi Maya, Christoph Eissler, Mitsuru Hirano, Naoko Nose, Hiroshi Wakabayashi, Constantin Lapa, Mehrbod S. Javadi, Takahiro Higuchi
The Impact of Ageing on 11C-Hydroxyephedrine Uptake in the Rat Heart
published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-018-29509-0
Scientific Reports 8/1 2019-03-12
2018 Rudolf A Werner, Hiroshi Wakabayashi, Jochen Bauer, Claudia Schütz, Christina Zechmeister, Nobuyuki Hayakawa, Mehrbod S Javadi, Constantin Lapa, Roland Jahns, Süleyman Ergün, Valerie Jahns, Takahiro Higuchi
Longitudinal 18F-FDG PET imaging in a rat model of autoimmune myocarditis
published pages: , ISSN: 2047-2404, DOI: 10.1093/ehjci/jey119
European Heart Journal - Cardiovascular Imaging 2019-03-12
2018 Xinyu Chen, Mitsuru Hirano, Rudolf A. Werner, Michael Decker, Takahiro Higuchi
Novel 18 F-Labeled PET Imaging Agent FV45 Targeting the Renin–Angiotensin System
published pages: 10460-10470, ISSN: 2470-1343, DOI: 10.1021/acsomega.8b01885
ACS Omega 3/9 2019-03-12
2018 Rudolf A. Werner
Cardiac innervation imaging as a risk stratification tool for potential device therapy candidates
published pages: , ISSN: 1071-3581, DOI: 10.1007/s12350-018-01475-0
Journal of Nuclear Cardiology 2019-03-12
2018 Rudolf A. Werner, Xinyu Chen, Steven P. Rowe, Constantin Lapa, Mehrbod S. Javadi, Takahiro Higuchi
Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers
published pages: , ISSN: 1569-5794, DOI: 10.1007/s10554-018-1469-z
The International Journal of Cardiovascular Imaging 2019-03-12

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NEUROHEART" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NEUROHEART" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

CoCoNat (2019)

Coordination in constrained and natural distributed systems

Read More  

PaSION (2018)

A longitudinal assessment of treatment experience, symptoms and potential associations with biomarkers in cancer patients undergoing immune checkpoint inhibitor therapy

Read More  

EVOMET (2019)

The rise and fall of metastatic clones under immune attack

Read More